Work

Real-world use of insertable cardiac monitor remote programming: A multicenter European experience

Year: 2025

Type: article

Abstract: Background: Insertable cardiac monitors (ICMs) enable continuous arrhythmia monitoring but generate high transmission volumes, increasing clinical workload. The LUX-Dx ICM (Boston Scientific) allows remote reprogramming of device alert settings, potentially reducing in-office visits. Objective: This study aimed to evaluate the real-world use of remote reprogramming after its initial commercialization in Europe and its impact on transmission burden. Methods: Deidentified data were collected from 697 consecutive patients across 23 European centers between 2022 and 2024. Results: < .001). Conclusion: ICM reprogramming plays a key role in optimizing device performance and reducing remote monitoring burden. Currently used in 39% of cases, remote reprogramming holds potential for broader adoption to minimize in-office visits. Efficiency may be further improved by transitioning to an alert-based monitoring strategy and eliminating scheduled transmissions.

Source: Heart Rhythm O2

DOI: 10.1016/j.hroo.2025.08.035